As of 2024-12-11, the Intrinsic Value of Isracann Biosciences Inc (IPOT.CN) is
-0.13 CAD. This IPOT.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.02 CAD, the upside of Isracann Biosciences Inc is
-963.67%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.13 CAD
Intrinsic Value
IPOT.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.13 - -0.13 |
-0.13 |
-963.67% |
| P/E |
(0.00) - (0.02) |
(0.00) |
-117.3% |
| DDM - Stable |
(0.36) - (2.50) |
(1.43) |
-9624.5% |
| DDM - Multi |
(0.35) - (1.93) |
(0.60) |
-4067.6% |
IPOT.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2.63 |
| Beta |
0.04 |
| Outstanding shares (mil) |
175.23 |
| Enterprise Value (mil) |
2.43 |
| Market risk premium |
5.10% |
| Cost of Equity |
7.01% |
| Cost of Debt |
5.00% |
| WACC |
5.35% |